Getinge AB Class B · OMXSTO:GETI_B
Getinge AB Class B — Investor Presentation (2000)
21 slides from Getinge AB Class B's investor presentation, 2000
Slide 1: Getinge Business Scope
Getinge Business Scope Infection control Geriatrics Customer Segments Business Areas Sterilization 42% Disinfection 13% Hygiene systems 17% Patienth handl. 14% Anti decubitus 9% Industry Acute Acutecare care Long Longterm termcare care Industry Pharma Pharma Medical Medicaldevice device Life LifeSci
Slide 2: Sales by region 1999
Sales by region 1999 Total Scientific Acute care Long time care Western Europe 51 % 52 % 38 % 62 % Eastern Europe 2% 1% 2% 1% North America 39 % 37 % 45 % 34 % Asia, Australia 6% 7% 11 % 3% Africa 1% 1% 2% 0% Latin Amerca 1% 1% 2% 0%
Slide 3: Getinge Industrier Results 1999
Getinge Industrier Results 1999 (MSEK) 9912 9812 % Orders received 4 932.2 4 304.0 14.6% Net sales 4 884.7 4 345.0 12.4% Operating profit 692.2 652.9 6.0% Operating profit 14.2% 15.0% -0.9% Financial net -55 -65 15.4 Profit before tax 636.2 602.6* 5.6% * (incl. 15.9 Lifco)
Slide 4: Balance sheet 9912
Balance sheet 9912 Assets Assets 1999 -12-31 1999-12-31 1998 -12-31 1998-12-31 Goodwill 1 012,7 1 034,2 Fixed assets 815,6 760,2 Stock-in-trade 765,3 770,7 Receivables 1 625,1 1 665,0 Liquid assets 158,8 196,6 Total assets 4 377,5 4 426,7 Shareholders’ Shareholders’ equity equity & & Liabilities Lia
Slide 5: Key figures
Key Key figures figures 1999 1999 1998 1998 Return on capital employed (%) 23,2 25,0 Shareholders’ equity per share (SEK) 34,4 26,9 Equity/Assets ratio (%) 35,7 27,6 Net Dept Ratio (%) 1,0 1,4 Interest cover, multiple 9,2 8,0
Slide 6: Statement of source
Statement Statement of of source source 1999 1999 1998 1998 Q4 Q4 99 99 Q4 Q4 98 98 Cash flow before changes in working capital 724,1 641,3 253,0 190,5 Changes in working capital - 119,6 - 523,0 - 48,4 141,5 Cash flow before investments 604,5 118,3 204,6 49,0 Operating cash flow 437,1 - 13,5 151,8 -
Slide 7: The Getinge Group
The Getinge Group 700 600 500 400 300 CAGR 200 NS 32,1 % EBIT 32,0 % 100 PBT 30,2 % 0 1993 1994 1995 1996 1997 1998 1999 Operating profit 3-D Column 2
Slide 8: Business Area Geriatrics
Business Area Geriatrics Disinfection Patient Handling Support Surface Solutions for: Hygiene Systems Nursing Homes Hospitals Assisted Living
Slide 9: Business Area Geriatrics: Market Shares
Business Area Geriatrics Market Shares Hygiene Systems Patient Handling Anti decubitus Market 1 400 MSEK 1 700 MSEK 8 000 MSEK Growth 5-7% 10 % 10 % Getinge 45 % Getinge 37 % Hillrom US 25 % Sunrise US 10 % Sunrise US 12 % KNCI US 20 % Sakai JP 8% Liko SE 7% Huntleigh UK 7 % Chiltern UK 4 % Guldman
Slide 10: Business Area Geriatrics: The Business Environment
Business Area Geriatrics The Business Environment Demography Financial constraints Trends in Long-term Care The Successful Supplier Capitated reimbursement Return on investments Care taker financing Ability to service chain accounts Privatisation Problem solver
Slide 11: Business Area Geriatrics: Growth opportunities
Business Area Geriatrics Growth opportunities (MSEK) Anti Total Growth* Market Assistive decubitus market* share* equipment Acute care 400 ? 45 % Growth Pene. Nursing 2000 5% 45 % Cons. / Pene. Pene. homes Care homes 900 10 % 25 % Growth - Domestic < 2700 7% - - care *) exclusive Anti decubitus
Slide 12: Business Area Geriatrics: Growth by Acquisition
Business Area Geriatrics Growth by Acquisition Patient Handling Complementary products Care Home Market Complementary products Showering Hygiene Systems Geographical expansion Japan Anti decubitus Critical mass Wound Care Strategy Medical Device Consumables
Slide 13: Business Area Geriatrics: Results
Business Area Geriatrics Results (MSEK) 1999 1999 Q4 99 Q4 98 Net sales 2 008 1 663 515 528 GM % 52.4% 53.4% 52.6% 50.6% Expenses 732 606 183 189 Ebit 320 283 88 78 Ebit % 16.0% 17.0% 17.2% 14.8%
Slide 14: Business Area Geriatrics: Strong product program
Business Area Geriatrics Strong product program Improved market coverage / reduced cost level in the US Improved market- & sales organisation Critical mass - Anti decubitus
Slide 15: Infection Control Scientific
Infection Control Scientific Water Treatment Sterilization Load Handling Complete Systems for: Production Washing Research / Laboratories Animal Care Facilities Food Industry
Slide 16: Infection Control Health Care
Infection Control Health Care Sterilization Complete Infection Control Systems for: Disinfection Central Processing Departments Outpatient Surgery Wards T-Doc System Infectious Waste Microbiology Pharmacies
Slide 17: Infection Control Results
Infection Control Results (MSEK) 1999 1998 Q4 99 Q4 98 Net sales 2 811 2 616 895 879 GM % 39.4% 39.3% 40.7% 39.3% Expenses 743 666 214 208 Ebit 365 363 150 138 Ebit % 13.0% 13.9% 16.8% 15.7%
Slide 18: Infection Control Market shares
Infection Control Market shares Sterilization Disinfection equipment Market 6200 MSEK 2500 MSEK Growth 5-7% 5-7% Getinge 23 % Getinge 26 % Steris US 21 % Miele DE 15 % Sakura JP 8% Steris US 9% J & J US 7% Meiko DE 8% MMM DE 6% Bellimed CH 5 % Fedegari IT 5% Matachana ES 2%
Slide 19: From Product to Solution
Infection Control Health Care From Product to Solution Sterilizer Disinfector Load handling Complete Logistics Infection Information management Control Consumables After Sales service Solutions Education From Cost to Revenue
Slide 20: Turn-Key Solutions for Health Care
Infection Control Health Care Turn-Key Solutions for Health Care Infection Customers Control Turn-Key Solutions Solutions for Outsourced within Hospitals Service Providers Getinge as Outsourced outside Hospitals Service Provider
Slide 21: Acquisitions Infection Control Health Care
Acquisitions Infection Control Health Care Existing business areas Sterilization / Disinfection ■ Geografical expansion - Spain, Germany, Japan ■ Consumables / Complementary products New business areas Acute care Operation Infection control